[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website
Drugs at FDA: FDA Approved Drug Products. Links to Initial Search Page FAQ  |  Instructions  |  Glossary  |  Contact Us  |  CDER Home 
Start Over (Drugs@FDA Home)

Drug Details
Drug Name(s) FIRMAGON (Brand Name Drug)
FDA Application No. (NDA) 022201
Active Ingredient(s) DEGARELIX ACETATE
Company FERRING
Original Approval or Tentative Approval Date December 24, 2008
Chemical Type 1  New molecular entity (NME)
Review Classification S  Standard review drug  

  • There are no Therapeutic Equivalents

Products on Application (NDA) #022201
    Click on a column header to re-sort the table:

Drug Name
Active Ingredients
Strength
Dosage Form/Route
Marketing
Status
RLD
TE
Code
FIRMAGON  DEGARELIX ACETATE  EQ 80MG BASE/VIAL  POWDER; SUBCUTANEOUS  Prescription  No None  
FIRMAGON  DEGARELIX ACETATE  EQ 120MG BASE/VIAL  POWDER; SUBCUTANEOUS  Prescription  Yes None  

Back to Top | Back to Previous Page | Back to Drugs@FDA Home

Disclaimer
CDER Home Page | Contact CDER | What's New @ CDER
FDA Home Page | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
Office of Training and Communications
Division of Information Services
Update Frequency: Daily